Share buybacks
First written in FY2017-Q2. 7 of 32 entries say "Restated". Latest entry: FY2026-H1.
- FY2026-H1Updated the treasury share balance at the interim period-end.Annual report
「(Treasury shares held) Fuso Pharmaceutical Industries,Ltd. 1-7-10 Doshomachi, Chuo-ku, Osaka 912,500 — 912,500 9.65」
As of 30 September 2025, treasury shares held totaled 912,500 shares, equivalent to 9.65% of total shares issued. This was up from 910,805 shares, or 9.64%, at FY2025 year-end. - FY2025Updated the full-year treasury share acquisitions and balance held.Annual report
「Treasury shares acquired during the fiscal year 4,352 4,301,139」
During the fiscal year, the company acquired 4,352 shares through the acquisition of less-than-one-unit shares and other transactions. Treasury shares held at fiscal year-end totaled 910,805 shares, equivalent to 9.64% of total shares issued. - FY2025-H1Updated the treasury share balance at the interim period-end.Annual report
「(Treasury shares held) Fuso Pharmaceutical Industries,Ltd. 1-7-10 Doshomachi Chuo-ku, Osaka City 908,500 — 908,500 9.61」
As of 30 September 2024, treasury shares held totaled 908,500, representing 9.61% of the total number of shares issued. This was an increase from the 906,453 held at the end of FY2024. - FY2024Updated the balance after full-year treasury share acquisitions and disposals.Annual report
「Treasury shares held 906,453」
The company acquired 306,800 treasury shares during the fiscal year and disposed of shares as restricted stock incentives and for other purposes. As a result, treasury shares held at fiscal year-end totaled 906,453, representing 9.59% of the total number of shares issued. - FY2024-Q3RestatedAnnual report
「Fuso Pharmaceutical Industries,Ltd. 1-7-10 Doshomachi Chuo-ku, Osaka City 988,600 — 988,600 10.46」
The company reconfirms that, as of 31 December 2023, treasury shares held totaled 988,600, representing 10.46% of the total number of shares issued. - FY2024-Q2Updated the acquisition of 306,800 treasury shares.Annual report
「Pursuant to a Board of Directors resolution dated 5 September 2023, the company acquired 306,800 treasury shares on 6 September 2023 through the Tokyo Stock Exchange's off-auction purchase of treasury shares (ToSTNeT-3).」
The company acquired 306,800 treasury shares on 6 September 2023. As of 30 September 2023, treasury shares held totaled 988,600, representing 10.46% of the total number of shares issued. - FY2024-Q1Updated the treasury share balance at the end of the first quarter.Annual report
「Fuso Pharmaceutical Industries,Ltd. 1-7-10 Doshomachi Chuo-ku, Osaka City 680,800 — 680,800 7.20」
As of 30 June 2023, treasury shares held totaled 680,800, representing 7.20% of the total number of shares issued. - FY2023Updated the full-year treasury share balance.Annual report
「Treasury shares held: 680,883」
As of 31 March 2023, treasury shares held totaled 680,883, representing 7.20% of the total number of shares issued. - FY2023-Q3RestatedAnnual report
「Fuso Pharmaceutical Industries,Ltd., 1-7-10 Doshomachi, Chuo-ku, Osaka City, 680,200 — 680,200 7.20」
As of 31 December 2022, treasury shares held totaled 680,200, representing 7.20% of the total number of shares issued, with no change from the previous quarter's disclosure. - FY2023-Q2Updated the treasury share balance at the end of the second quarter.Annual report
「(Treasury shares held) Fuso Pharmaceutical Industries,Ltd., 1-7-10 Doshomachi, Chuo-ku, Osaka City, 680,200 — 680,200 7.20」
As of 30 September 2022, treasury shares held totaled 680,200, representing 7.20% of the total number of shares issued. - FY2023-Q1Updated the treasury share balance at the end of the first quarter.Annual report
「679,200 ― 679,200 7.19」
As of 30 June 2022, treasury shares held totaled 679,200, representing 7.19% of the total number of shares issued, a decrease of 42 shares from the 679,242 held at the end of the previous fiscal year. - FY2022Updated the full-year treasury share balance.Annual report
「Of the 679,242 treasury shares, 6,792 units are included under “Individuals and Others,” and 42 shares are included under “Status of Shares Less Than One Unit.”」
As of 31 March 2022, treasury shares held totaled 679,242, representing 7.19% of the total number of shares issued. - FY2022-Q2Updated the treasury share balance at the end of the second quarter.Annual report
「Fuso Pharmaceutical Industries,Ltd., 1-7-10 Doshomachi, Chuo-ku, Osaka City, 678,800 — 678,800 7.18」
As of 30 September 2021, treasury shares held totaled 678,800, representing 7.18% of the total number of shares issued. This was an increase of 400 shares from the previous figure of 678,400. - FY2022-Q1Updated the treasury share balance at the end of the first quarter.Annual report
「Fuso Pharmaceutical Industries,Ltd., 1-7-10 Doshomachi, Chuo-ku, Osaka City, 678,400 — 678,400 7.18」
As of 30 June 2021, treasury shares held totaled 678,400, representing 7.18% of the total number of shares issued. - FY2021Updated the full-year treasury share balance.Annual report
「Treasury shares held: 678,420」
As of 31 March 2021, treasury shares held totaled 678,420, representing 7.18% of the total number of shares issued. - FY2021-Q3RestatedAnnual report
「Fuso Pharmaceutical Industries,Ltd., 1-7-10 Doshomachi, Chuo-ku, Osaka City, 677,400 — 677,400 7.17」
As of 31 December 2020, treasury shares held totaled 677,400, representing 7.17% of the total number of shares issued, with no change from the previous quarter's disclosure. - FY2021-Q2Updated the treasury share balance at the end of the second quarter.Annual report
「Fuso Pharmaceutical Industries,Ltd., 1-7-10 Doshomachi, Chuo-ku, Osaka City, 677,400 — 677,400 7.17」
As of 30 September 2020, treasury shares held totaled 677,400, representing 7.17% of the total number of shares issued. - FY2021-Q1RestatedAnnual report
「676,800 ― 676,800 7.16」
As of 30 June 2020, treasury shares held totaled 676,800, representing 7.16% of the total number of shares issued, with no change from fiscal year-end. - FY2020Updated the full-year treasury share balance.Annual report
「676,800 ― 676,800 7.16」
As of 31 March 2020, treasury shares held totaled 676,800, representing 7.16% of the total number of shares issued. - FY2020-Q3RestatedAnnual report
「676,100 ― 676,100 7.15」
As of 31 December 2019, treasury shares held totaled 676,100, representing 7.15% of the total number of shares issued, with no change from the previous quarter's disclosure. - FY2020-Q2Updated the treasury share balance at the end of the second quarter.Annual report
「676,100 ― 676,100 7.15」
As of 30 September 2019, treasury shares held totaled 676,100, representing 7.15% of the total number of shares issued. - FY2020-Q1Updated the treasury share balance at the end of the first quarter.Annual report
「675,500 ― 675,500 7.15」
As of 30 June 2019, treasury shares held totaled 675,500, representing 7.15% of the total number of shares issued. - FY2019Updated the full-year treasury share balance.Annual report
「Treasury shares held: 675,566」
At the end of FY2019, treasury shares held totaled 675,566, representing 7.15% of the total number of shares issued. - FY2019-Q3RestatedAnnual report
「674,300 ― 674,300 7.14」
As of 31 December 2018, treasury shares held totaled 674,300, representing 7.14% of the total number of shares issued, with no change from the previous quarter's disclosure. - FY2019-Q2Updated the treasury share balance at the end of the second quarter.Annual report
「674,300 ― 674,300 7.14」
As of 30 September 2018, treasury shares held totaled 674,300, representing 7.14% of the total number of shares issued. This was an increase from the previous figures of 673,100 shares and 7.12%. - FY2019-Q1Updated the treasury share balance at the end of the first quarter.Annual report
「673,100 ― 673,100 7.12」
As of 30 June 2018, treasury shares held totaled 673,100, representing 7.12% of the total number of shares issued. - FY2018Updated the full-year treasury share acquisitions and balance held.Annual report
「Treasury shares held: 673,157」
The company acquired 154,100 shares during the fiscal year. At fiscal year-end, treasury shares held totaled 673,157, representing 7.12% of the total number of shares issued. - FY2018-Q3RestatedAnnual report
「(Treasury shares held) Fuso Pharmaceutical Industries,Ltd., 1-7-10 Doshomachi, Chuo-ku, Osaka City, 672,400 — 672,400 7.12」
The company reports 672,400 treasury shares held as of 31 December 2017, representing 7.12% of the total number of shares issued, with no change from the previous quarter's disclosure. - FY2018-Q2Updated treasury share balanceAnnual report
「The company holds 672 thousand treasury shares (7.12%).」
The treasury share balance was 672,400 shares, representing 7.12% of the total number of shares issued. This was an increase from the previously reported 516,900 shares and 5.47%; payments for the acquisition of treasury shares during the first half totaled ¥425 million. - FY2018-Q1Updated treasury share balanceAnnual report
「Held in own name: 516,900 shares; percentage of shares held: 5.47%」
The company reports 516,900 treasury shares held as of 30 June 2017, representing 5.47% of the total number of shares issued. - FY2017Updated the full-year treasury share acquisition results.Annual report
「Treasury shares acquired during the fiscal year: 1,050,000」
For the full year, payments for the acquisition of treasury shares totaled ¥282 million, including the acquisition of 1,050,000 treasury shares pursuant to a Board of Directors resolution. - FY2017-Q2First statedAnnual report
「Cash outflow for the acquisition of treasury shares」
The cash flow from financing activities for the six months ended in the second quarter includes ¥274 million in payments for the acquisition of treasury shares.